title: [Adiponectin and parameters of glucose and lipid metabolism at different clinical and morphological stages of non-alcoholic fatty liver disease in patients with abdominal obesity].
abstract: OBJECTIVE
  To compare clinical, laboratory, and morphological parameters in patients with abdominal obesity and non-alcoholic fatty liver disease (NAFLD) and to assess the relationship between the degree and stage of the disease and the cardiometabolic risk factors of type 2 diabetes mellitus and cardiovascular diseases.
  
  
  METHODS
  Eighty patients aged 30 to 50 years with abdominal obesity were examined. NAFLD was diagnosed after liver puncture biopsy. The parameters of carbohydrate and lipid metabolism and the activity of hepatic transaminases and the protective adipocytokine adiponectin were investigated.
  
  
  RESULTS
  NAFLD was verified in 77 examinees. Metabolic disturbances were found in the majority of the examinees with abdominal obesity and NAFLD; they were concurrent and increased in their rate and degree with the progression of NAFLD, obesity, and insulin resistance. The patients with NAFLD had a significantly decreased adiponectin level that got worse as NAFLD progressed.
  
  
  CONCLUSIONS
  The investigation has revealed that NAFLD is associated with cardiometabolic disorders (dyslipidemia, carbohydrate metabolic disturbances, and insulin resistance) increasing in their rate and degree with the progression of NAFLD and the lower adiponectin level reducing as NAFLD worsens.
authors.forename: K A
authors.initials: KA
authors.lastname: Komshilova
authors.forename: E A
authors.initials: EA
authors.lastname: Troshina
authors.forename: E V
authors.initials: EV
authors.lastname: Ershova
authors.forename: N V
authors.initials: NV
authors.lastname: Mazurina
authors.forename: N M
authors.initials: NM
authors.lastname: Platonova
mesh_terms: D052242:Adiponectin / Q000378:metabolism*; D000328:Adult; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology*; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis / Q000378:metabolism*; D056128:Obesity, Abdominal / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D052242:Adiponectin; D005947:Glucose